Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19 Pt 1
pubmed:dateCreated
2005-10-5
pubmed:abstractText
Patients with ovarian clear cell adenocarcinoma generally have a poor response to combination chemotherapy and have overall poorer prognosis than patients with other histologic types of ovarian cancer. Genetic changes in this group of cancer have not been thoroughly explored. Identification of these changes may provide us new therapeutic targets to treat this disease.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6880-8
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:16203778-ATP-Binding Cassette Transporters, pubmed-meshheading:16203778-Adenocarcinoma, Clear Cell, pubmed-meshheading:16203778-Adult, pubmed-meshheading:16203778-Aged, pubmed-meshheading:16203778-Blotting, Western, pubmed-meshheading:16203778-Cell Line, pubmed-meshheading:16203778-Cell Line, Tumor, pubmed-meshheading:16203778-Cytoplasm, pubmed-meshheading:16203778-DNA, pubmed-meshheading:16203778-DNA, Complementary, pubmed-meshheading:16203778-Female, pubmed-meshheading:16203778-Gene Expression Profiling, pubmed-meshheading:16203778-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16203778-Humans, pubmed-meshheading:16203778-Middle Aged, pubmed-meshheading:16203778-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:16203778-Oligonucleotides, pubmed-meshheading:16203778-Ovarian Neoplasms, pubmed-meshheading:16203778-Prognosis, pubmed-meshheading:16203778-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16203778-Transfection, pubmed-meshheading:16203778-Treatment Outcome, pubmed-meshheading:16203778-Tumor Markers, Biological
pubmed:year
2005
pubmed:articleTitle
Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.
pubmed:affiliation
Department of Obstetrics and Gynecology, Laboratory of Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural